To resume

AbbVie, AstraZeneca See the value in what Cugene, Proteros have to offer

AbbVie, AstraZeneca See the value in what Cugene, Proteros have to offer

It is common for smaller biotech companies with interesting technology platforms to partner with larger biopharmaceutical companies. Two such deals were announced today: Cugene and AbbVie on autoimmune diseases and cancer, and Proteros and AstraZeneca on epigenetic anticancer drugs. Read on for more details. AbbVie and Cugene collaborate on autoimmune diseases and cancer Based in …

AbbVie, AstraZeneca See the value in what Cugene, Proteros have to offer Read More »

BioSpace Movers & Shakers: Jeffrey Leiden, Don Hayden, Zentalis, Entera and others

BioSpace Movers & Shakers: Jeffrey Leiden, Don Hayden, Zentalis, Entera and others

Renowned executives and leaders in the biopharmaceutical industry, including Vertex Pharmaceuticals founder Jeffrey Leiden and BMS veteran Don Hayden, help several companies around the world strengthen their teams and boards. Here’s a look at the last one. Zentalis pharmaceuticals: Kimberly Blackwell will be successful Anthony Sun as CEO of Zentalis Pharmaceuticals. Blackwell previously served as …

BioSpace Movers & Shakers: Jeffrey Leiden, Don Hayden, Zentalis, Entera and others Read More »

Because now is the best time to move to the pharmaceutical and biotech sector

Because now is the best time to move to the pharmaceutical and biotech sector

Changing career paths will always seem like a daunting undertaking and there is no perfect time to do it. And as if that weren’t enough, there will almost always be adversaries and tough times along the way to secure your new job. But that doesn’t mean you shouldn’t try. If you are interested in biopharmaceuticals …

Because now is the best time to move to the pharmaceutical and biotech sector Read More »

Kevin Gould, CEO of Axion BioSystems (photo: Business Wire)

Axion BioSystems welcomes biotech industry leader Kevin Gould as the new CEO

This press release contains multimedia content. View the full version here: https://www.businesswire.com/news/home/20220515005001/en/ Kevin Gould, CEO of Axion BioSystems (photo: Business Wire) Kevin today takes over from Axion’s longtime CEO Tom O’Brien, who will retire on July 15th. O’Brien, who co-founded Axion BioSystems in 2008 with Chief Technical Officer Jim Ross, said Gould is a natural …

Axion BioSystems welcomes biotech industry leader Kevin Gould as the new CEO Read More »

Cytovia becomes public in the SPAC agreement in the midst of the Slow Biotech IPO environment

Cytovia becomes public in the SPAC agreement in the midst of the Slow Biotech IPO environment

Cytovia CEO Daniel Teper / Courtesy of Cytovia Therapeutics Cytovia Holdingsa biopharmaceutical company focused on natural killer (NK) cells, announced a to merger with Special Purpose Acquisition Company (SPAC) Isleworth Healthcare Acquisition Corp. through which it will go public. Isleworth is led by Al Weiss, former president, of Worldwide Operations for Walt Disney Parks and …

Cytovia becomes public in the SPAC agreement in the midst of the Slow Biotech IPO environment Read More »

Plan your digital strategy ahead of time to avoid the new biotechnology bottleneck

Plan your digital strategy ahead of time to avoid the new biotechnology bottleneck

In the quest to develop science and raise money, developing a digital strategy in general is an afterthought for fledgling biotech companies, when you consider it. Not paying attention to it in advance, however, can hinder their ability to advance their science and limit their revenue generation options. With data stored with various researchers and …

Plan your digital strategy ahead of time to avoid the new biotechnology bottleneck Read More »

BioSpace Movers & Shaker: singular genomics, Marengo, Ventyx, Caribou and more

BioSpace Movers & Shaker: singular genomics, Marengo, Ventyx, Caribou and more

Building stronger companies requires the right leadership. This week, life science companies around the world identify the Movers & Shakers who will benefit the most from their company. Singular genomics: Singular Genomics Systems, Inc., headquartered in California formed its scientific committee. New members include David L. Barker, member of the board of directors of Singular …

BioSpace Movers & Shaker: singular genomics, Marengo, Ventyx, Caribou and more Read More »

(PRNewsfoto / Curative Biotechnology, Inc.)

Curative Biotechnology, Inc. appoints Cary Sucoff to the board of directors

The appointment of the Independent Director adds to the financial responsibilities of the Board BOCA RATON, Fla., May 12, 2022 / PRNewswire / – Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or “Company”), a developing biomedical company focused on new treatments for rare diseases and conditions, announced today that Cary Sucoff he …

Curative Biotechnology, Inc. appoints Cary Sucoff to the board of directors Read More »

(PRNewsfoto / Curative Biotechnology, Inc.)

Curative Biotechnology, Inc. appoints Cary Sucoff to the board of directors

The appointment of the Independent Director adds to the financial responsibilities of the Board BOCA RATON, Fla., May 12, 2022 / PRNewswire / – Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or “Company”), a developing biomedical company focused on new treatments for rare diseases and conditions, announced today that Cary Sucoff he …

Curative Biotechnology, Inc. appoints Cary Sucoff to the board of directors Read More »